Linike Medical Group Ltd.
LNMG
$0.0061
$0.00011.67%
OTC PK
| 07/31/2014 | 04/30/2014 | 01/31/2014 | 10/31/2013 | 07/31/2013 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -81.36% | -74.90% | -25.10% | -70.94% | 388.62% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -81.40% | -75.06% | -25.10% | 178.41% | 389.43% |
| Operating Income | 81.40% | 75.06% | 25.10% | -178.41% | -389.43% |
| Income Before Tax | 83.17% | 71.36% | 25.10% | -179.36% | -402.44% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 83.17% | 71.36% | 25.10% | -179.36% | -402.44% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 83.17% | 71.36% | 25.10% | -179.36% | -402.44% |
| EBIT | 81.40% | 75.06% | 25.10% | -178.41% | -389.43% |
| EBITDA | 81.70% | 75.22% | -- | -- | -- |
| EPS Basic | 92.37% | 86.96% | 91.69% | 71.03% | 12.86% |
| Normalized Basic EPS | 92.24% | 87.03% | 91.66% | 71.06% | 13.12% |
| EPS Diluted | 92.37% | 86.96% | 91.69% | 71.03% | 12.86% |
| Normalized Diluted EPS | 92.24% | 87.03% | 91.66% | 71.06% | 13.12% |
| Average Basic Shares Outstanding | 120.97% | 120.97% | 801.48% | 864.52% | 477.41% |
| Average Diluted Shares Outstanding | 120.97% | 120.97% | 801.48% | 864.52% | 477.41% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |